- call +1-201-465-4211
- email sales@mrinsights.biz
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Scope of the Report:
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
The worldwide market for Congestive Heart Failure (CHF) Treatment Devices is expected to grow at a CAGR of roughly 5.7% over the next five years, will reach 15400 million US$ in 2023, from 11000 million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Congestive Heart Failure (CHF) Treatment Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Abiomed, Inc.
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International, Inc.
Jarvik Heart, Inc.
LivaNova PLC
Medtronic
ReliantHeart Inc.
St. Jude Medical, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Market Segment by Applications, can be divided into
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
There are 15 Chapters to deeply display the global Congestive Heart Failure (CHF) Treatment Devices market.
Chapter 1, to describe Congestive Heart Failure (CHF) Treatment Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Congestive Heart Failure (CHF) Treatment Devices, with sales, revenue, and price of Congestive Heart Failure (CHF) Treatment Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Congestive Heart Failure (CHF) Treatment Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Congestive Heart Failure (CHF) Treatment Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Congestive Heart Failure (CHF) Treatment Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Congestive Heart Failure (CHF) Treatment Devices Introduction
1.2 Market Analysis by Type
1.2.1 Cardiac Resynchronization Therapy (CRT)
1.2.2 Implantable Cardioverter Defibrillators (ICDs)
1.3 Market Analysis by Applications
1.3.1 Left Ventricular Assist Device (LVAD)
1.3.2 Right Ventricular Assist Device (RVAD)
1.3.3 Biventricular Assist Device (BIVAD)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abiomed, Inc.
2.1.1 Business Overview
2.1.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abiomed, Inc. Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Berlin Heart GmbH
2.2.1 Business Overview
2.2.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biotronik SE & Co. KG
2.3.1 Business Overview
2.3.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Boston Scientific Corporation
2.4.1 Business Overview
2.4.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 HeartWare International, Inc.
2.5.1 Business Overview
2.5.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 HeartWare International, Inc. Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Jarvik Heart, Inc.
2.6.1 Business Overview
2.6.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Jarvik Heart, Inc. Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 LivaNova PLC
2.7.1 Business Overview
2.7.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medtronic
2.8.1 Business Overview
2.8.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 ReliantHeart Inc.
2.9.1 Business Overview
2.9.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ReliantHeart Inc. Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 St. Jude Medical, Inc.
2.10.1 Business Overview
2.10.2 Congestive Heart Failure (CHF) Treatment Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 St. Jude Medical, Inc. Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Congestive Heart Failure (CHF) Treatment Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Congestive Heart Failure (CHF) Treatment Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Regions
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
4.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
4.5 South America Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
5 North America Congestive Heart Failure (CHF) Treatment Devices by Countries
5.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
5.3 Canada Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
6 Europe Congestive Heart Failure (CHF) Treatment Devices by Countries
6.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
6.3 UK Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
6.4 France Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
6.5 Russia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
6.6 Italy Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices by Countries
7.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
7.3 Japan Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
7.4 Korea Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
7.5 India Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
8 South America Congestive Heart Failure (CHF) Treatment Devices by Countries
8.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices by Countries
9.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
9.3 UAE Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2013-2018)
10 Global Congestive Heart Failure (CHF) Treatment Devices Market Segment by Type
10.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Type (2013-2018)
10.2 Cardiac Resynchronization Therapy (CRT) Sales Growth and Price
10.2.1 Global Cardiac Resynchronization Therapy (CRT) Sales Growth (2013-2018)
10.2.2 Global Cardiac Resynchronization Therapy (CRT) Price (2013-2018)
10.3 Implantable Cardioverter Defibrillators (ICDs) Sales Growth and Price
10.3.1 Global Implantable Cardioverter Defibrillators (ICDs) Sales Growth (2013-2018)
10.3.2 Global Implantable Cardioverter Defibrillators (ICDs) Price (2013-2018)
11 Global Congestive Heart Failure (CHF) Treatment Devices Market Segment by Application
11.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2013-2018)
11.2 Left Ventricular Assist Device (LVAD) Sales Growth (2013-2018)
11.3 Right Ventricular Assist Device (RVAD) Sales Growth (2013-2018)
11.4 Biventricular Assist Device (BIVAD) Sales Growth (2013-2018)
12 Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2018-2023)
12.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Congestive Heart Failure (CHF) Treatment Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2018-2023)
12.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2018-2023)
12.2.4 South America Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2018-2023)
12.3 Congestive Heart Failure (CHF) Treatment Devices Market Forecast by Type (2018-2023)
12.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Share Forecast by Type (2018-2023)
12.4 Congestive Heart Failure (CHF) Treatment Devices Market Forecast by Application (2018-2023)
12.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Congestive Heart Failure (CHF) Treatment Devices Picture
Table Product Specifications of Congestive Heart Failure (CHF) Treatment Devices
Figure Global Sales Market
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
